There's plenty of talk about enterprises building hybrid clouds that contain the appropriate mix of public cloud and private resources. But there's not a lot of choices available to securely move or manage workloads across such disparate environments.
This was a challenge faced by Barcelona, Spain-based pharmaceutical and chemical research firm Mind the Byte. Mind the Byte provides its chemo and bioinformatics web platform iMols to researchers who need to compile various molecules, proteins and activities databases. Results, according to Mind the Byte founder Alfons Nonell-Canals, are delivered within a few seconds, or days.
Like many companies, this one chose to deploy its services on clouds rather than build their own data center. Today, Mind the Byte manages its systems from Barcelona, stores its biochemical data in Amazon S3 and accesses and processes them via iMols running on EC2 instances in Amazon's Virginia data center. For a time the company also ran part of its systems within a Netherlands-based data center, close to its European customers.
To continue reading, register here to become an Insider. You'll get free access to premium content from CIO, Computerworld, CSO, InfoWorld, and Network World. See more Insider content or sign in.